Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Reteplase

Reteplase

pharmaceutical raw materials
Reteplase structure

Reteplase 

structure

Description

Reteplase was launched in Germany and the US for acute myocardial infarction. Retevase is a single chain recombinant form of tissue plasminogen activator (t-PA) with all except the kringle-2 and protease domains deleted. When expressed in E. coli the inactive form is produced and stored in inclusion bodies. After purification and an in vitro refolding process the active form is obtained. The expression in E. coli gives rise to a non-glycosylated protein. This and the deletion of several d

Reteplase Use and Manufacturing

Myocardial infarction therapy; plasminogen activator.

Drug Function and Efficacy

It can activate plasminogen into active plasmin to degrade fibrin in thrombus and play a thrombolytic role

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.